drugset / Trial / NCT06811246
A Clinical Study of Islatravir and Its Interaction With Lamivudine (MK-8591-058)
NaSingle-groupOpen-labelBasic science
Summary
The goal of this study is to learn what happens to the medication islatravir (ISL), in a healthy person's body over time--called a pharmacokinetic (PK) study. Researchers want to compare the amount of islatravir in the blood when it is taken alone as a single dose and when it is taken with multiple doses of another medication called lamivudine (3TC).
Timeline
- Start
- 2024-02-07
- Primary completion
- 2024-07-14
- Completion
- 2024-07-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Islatravir | Other / unclassified | — | Oral |
| Subject | Lamivudine | Other / unclassified | — | Oral |
Indications
No indication recorded.